Letters to the Editor
Macrophage activation syndrome after BNT162b2 mRNA vaccination successfully treated with corticosteroids
N. Ashizawa1, T. Takazono2, M. Umeda3, K. Yamamoto4, A. Kawakami5, H. Mukae6
- Infection Control and Education Center, and Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
- Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, and Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. takahiro-takazono@nagasaki-u.ac.jp
- Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
- Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
- Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
- Department of Respiratory Medicine, Nagasaki University Hospital, and Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
CER15130
2022 Vol.40, N°5
PI 1060
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 35084316 [PubMed]
Received: 02/09/2021
Accepted : 08/11/2021
In Press: 05/01/2022
Published: 13/05/2022
